Breast Cancer Clinical Trials in Michigan

Showing 121-140 of 478 trials

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.

Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more

Volastra Therapeutics, Inc.200 participantsStarted Oct 2023

Los Angeles, California, United States • Newport Beach, California, United States • Aurora, Colorado, United States +11 more locations

COMPLETEDPhase 1/2102 miles

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

NCT05383170

This Phase 1b/2a study will assess the efficacy, safety, and pharmacodynamics of CyPep-1 when administered directly into measurable tumor lesions in combination with the anti-PD-1 antibody pembrolizumab. Additionally, the study will assess anti-tumor effects of CyPep-1 on injected lesions and non-injected target lesions identified at baseline, as well as local and systemic immunological effects of CyPep-1 in combination with pembrolizumab.

Advanced Head and Neck Squamous Cell CarcinomaAdvanced Breast CancerAdvanced Melanoma

Cytovation AS6 participantsStarted Mar 2023

Birmingham, Alabama, United States • Duarte, California, United States • Detroit, Michigan, United States +22 more locations

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Breast Cancer Trials in Other Cities

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

A Study of XMT-1660 in Participants With Solid Tumors

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery

Study of AVZO-021 in Patients With Advanced Solid Tumors

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

MARGetuximab Or Trastuzumab (MARGOT)

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

A Study of PF-06873600 in People With Cancer

QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

Other Conditions in Michigan